Your browser doesn't support javascript.
Reply to: Utility of Serum S100B as a Marker in SLE Patients During and After the SARS-Cov-2 Pandemic.
Zhou, Si-Yu; Shu, Wen-Jing; Pan, Hai-Feng.
  • Zhou SY; Department of Clinical Medicine, The First School of Clinical Medicine, Anhui Medical University, Hefei, Anhui, China.
  • Shu WJ; Department of Clinical Medicine, The First School of Clinical Medicine, Anhui Medical University, Hefei, Anhui, China.
  • Pan HF; Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Hefei, Anhui 230032, China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, Anhui, China. Electronic address: panhaifeng1982@sina.com.
Arch Med Res ; 53(5): 545, 2022 07.
Article in English | MEDLINE | ID: covidwho-1866882

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Lupus Erythematosus, Systemic Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Arch Med Res Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: J.arcmed.2022.05.005

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Lupus Erythematosus, Systemic Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Arch Med Res Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: J.arcmed.2022.05.005